|
1
|
Gillum RF: Pulmonary embolism and
thrombophlebitis in the United States, 1970-1985. Am Heart J.
114:1262–1264. 1987.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Heit JA, Silverstein MD, Mohr DN,
Petterson TM, Lohse CM, O'Fallon WM and Melton LJ III: The
epidemiology of venous thromboembolism in the community. Thromb
Haemost. 86:452–463. 2001.PubMed/NCBI
|
|
3
|
Heit JA: The epidemiology of venous
thromboembolism in the community: Implications for prevention and
management. J Thromb Thrombolys. 21:23–29. 2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Heit JA: Predicting the risk of venous
thromboembolism recurrence. Am J Hematol. 87 (Suppl 1):S63–S67.
2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kearon C, Akl EA, Ornelas J, Blaivas A,
Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, et
al: Antithrombotic therapy for VTE disease: CHEST guideline and
expert panel report. Chest. 149:315–352. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kearon C, Ageno W, Cannegieter SC, Cosmi
B, Geersing GJ and Kyrle PA: Categorization of patients as having
provoked or unprovoked venous thromboembolism: Guidance from the
SSC of ISTH. J Thromb Haemost. 14:1480–1483. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Konstantinides SV, Meyer G, Becattini C,
Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings
CS, Jiménez D, et al: 2019 ESC Guidelines for the diagnosis and
management of acute pulmonary embolism developed in collaboration
with the European Respiratory Society (ERS). Eur Heart J.
41:543–603. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schulman S, Kearon C, Kakkar AK, Mismetti
P, Schellong S, Eriksson H, Baanstra D, Schnee J and Goldhaber SZ:
RE-COVER Study Group. Dabigatran versus warfarin in the treatment
of acute venous thromboembolism. N Engl J Med. 361:2342–2352.
2009.
|
|
9
|
Schulman S, Kakkar AK, Goldhaber SZ,
Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J,
Le Maulf F, Peter N, et al: Treatment of acute venous
thromboembolism with dabigatran or warfarin and pooled analysis.
Circulation. 129:764–772. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Schulman S and Kearon C: Definition of
major bleeding in clinical investigations of antihemostatic
medicinal products in non-surgical patients. J Thromb Haemost.
3:692–694. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pisters R, Lane DA, Nieuwlaat R, de Vos
CB, Crijns HJ and Lip GY: A novel user-friendly score (HAS-BLED) to
assess 1-year risk of major bleeding in patients with atrial
fibrillation: The Euro Heart Survey. Chest. 138:1032–1033.
2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gage BF, Yan Y, Milligan PE, Waterman AD,
Culverhouse R, Rich MW and Radford MJ: Clinical classification
schemes for predicting hemorrhage: Results from the National
Registry of Atrial Fibrillation (NRAF). Am Heart J. 151:713–719.
2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Singer DE, Chang Y, Borowsky LH, Fang MC,
Pomernacki NK, Udaltsova N, Reynolds K and Go AS: A new risk scheme
to predict ischemic stroke and other thromboembolism in atrial
fibrillation: The ATRIA study stroke risk score. J Am Heart Assoc.
2(e000250)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Klok FA, Kooiman J, Huisman MV,
Konstantinides S and Lankeit M: Predicting anticoagulant-related
bleeding in patients with venous thromboembolism: A clinically
oriented review. Eur Respir J. 45:201–210. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ruíz-Giménez N, Suárez C, González R,
Nieto JA, Todolí JA, Samperiz AL and Monreal M: RIETE
Investigators. Predictive variables for major bleeding events in
patients presenting with documented acute venous thromboembolism.
Findings from the RIETE Registry. Thromb Haemost. 100:26–31.
2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Di Nisio M, Ageno W, Rutjes AW, Pap AF and
Büller HR: Risk of major bleeding in patients with venous
thromboembolism treated with rivaroxaban or with heparin and
vitamin K antagonists. Thromb Haemost. 115:424–432. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Di Nisio M, Raskob G, Büller HR, Grosso
MA, Zhang G, Winters SM and Cohen A: Prediction of major and
clinically relevant bleeding in patients with VTE treated with
edoxaban or vitamin K antagonists. Thromb Haemost. 117:784–793.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ageno W, Gallus AS, Wittkowsky A, Crowther
M, Hylek EM and Palareti G: Oral anticoagulant therapy:
Antithrombotic therapy and prevention of thrombosis, 9th ed:
American College of Chest Physicians Evidence-Based Clinical
Practice Guidelines. Chest. 141 (Suppl 2):e44S–e88S.
2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Klok FA, Niemann C, Dellas C, Hasenfuß G,
Konstantinides S and Lankeit M: Performance of five different
bleeding-prediction scores in patients with acute pulmonary
embolism. J Thromb Thrombolysis. 41:312–320. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kresoja KP, Ebner M, Rogge NIJ, Sentler C,
Keller K, Hobohm L, Hasenfuß G, Konstantinides SV, Pieske B and
Lankeit M: Prediction and prognostic importance of in-hospital
major bleeding in a real-world cohort of patients with pulmonary
embolism. Int J Cardiol. 290:144–149. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kangelaris KN, Bent S, Nussbaum RL, Garcia
DA and Tice JA: Genetic testing before anticoagulation? A
systematic review of pharmacogenetic dosing of warfarin. J Gen
Intern Med. 24:656–664. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Klok FA, Hösel V, Clemens A, Yollo WD,
Tilke C, Schulman S, Lankeit M and Konstantinides SV: Prediction of
bleeding events in patients with venous thromboembolism on stable
anticoagulation treatment. Eur Respir J. 48:1369–1376.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Klok FA, Presles E, Tromeur C, Barco S,
Konstantinides SV, Sanchez O, Pernod G, Raj L, Robin P, Le Roux PY,
et al: Evaluation of the predictive value of the bleeding
prediction score VTE-BLEED for recurrent venous thromboembolism.
Res Pract Thromb Haemost. 3:364–371. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Brown JD, Goodin AJ, Lip GYH and Adams VR:
Risk stratification for bleeding complications in patients with
venous thromboembolism: Application of the HAS-BLED bleeding score
during the first 6 months of anticoagulant treatment. J Am Heart
Assoc. 7(e007901)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Eichinger S, Heinze G, Jandeck LM and
Kyrle PA: Risk assessment of recurrence in patients with unprovoked
deep vein thrombosis or pulmonary embolism: The Vienna prediction
model. Circulation. 121:1630–1636. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tosetto A, Iorio A, Marcucci M, Baglin T,
Cushman M, Eichinger S, Palareti G, Poli D, Tait RC and Douketis J:
Predicting disease recurrence in patients with previous unprovoked
venous thromboembolism: A proposed prediction score (DASH). J
Thromb Haemost. 10:1019–1025. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Klok FA, Barco S and Konstantinides SV:
External validation of the VTE-BLEED score for predicting major
bleeding in stable anticoagulated patients with venous
thromboembolism. Thromb Haemost. 117:1164–1170. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shipe ME, Deppen SA, Farjah F and Grogan
EL: Developing prediction models for clinical use using logistic
regression: An overview. J Thorac Dis. 11 (Suppl 4):S574–S584.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Morotti A and Goldstein JN:
Anticoagulant-associated intracerebral hemorrhage. Brain
Hemorrhages. 1:89–94. 2020.
|
|
30
|
Hokusai-VTE Investigators. Büller HR,
Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob
GE, Schellong SM, Schwocho L, et al: Edoxaban versus warfarin for
the treatment of symptomatic venous thromboembolism. N Engl J Med.
369:1406–1415. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Klok FA, Barco S and Konstantinides SV:
Evaluation of VTE-BLEED for predicting intracranial or fatal
bleeding in stable anticoagulated patients with venous
thromboembolism. Eur Respir J. 51(1800077)2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Klok FA, Barco S, Turpie AGG, Haas S,
Kreutz R, Mantovani LG, Gebel M, Herpers M, Bugge JP, Kostantinides
SV and Ageno W: Predictive value of venous thromboembolism
(VTE)-BLEED to predict major bleeding and other adverse events in a
practice-based cohort of patients with VTE: Results of the XALIA
study. Br J Haematol. 183:457–465. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Nishimoto Y, Yamashita Y, Morimoto T, Saga
S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, et al:
Validation of the VTE-BLEED score's long-term performance for major
bleeding in patients with venous thromboembolisms: From the COMMAND
VTE registry. J Thromb Haemost. 18:624–632. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Vedovati MC, Mancuso A, Pierpaoli L,
Paliani U, Conti S, Ascani A, Galeotti G, Di Filippo F, Caponi C,
Agnelli G and Becattini C: Prediction of major bleeding in patients
receiving DOACs for venous thromboembolism: A prospective cohort
study. Int J Cardiol. 301:167–172. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hidalgo Soto M, Zamanillo Herreros I, Diaz
Pedroche C, Gómez Cuervo C, Vera Guerrero E, Lóopez Muñoz N, De
Nicolás Sol R, Gutierrez de Ocariz X, Buendía Ureña B, Iñiguez
García R, et al: VTE-BLEED score to predict bleeding complications
in patients with venous thromboembolism: From the RIETE Registry.
Virtual Edition of the 25th European Hematology Association (EHA)
Annual Congress. (S324)2020.
|
|
36
|
Proietti M, Senoo K, Lane DA and Lip GY:
Major bleeding in patients with non-valvular atrial fibrillation:
Impact of time in therapeutic range on contemporary bleeding risk
scores. Sci Rep. 6(24376)2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Becattini C, Giustozzi M, Ranalli MG,
Bogliari G, Cianella F, Verso M, Agnelli G and Vedovati MC:
Variation of renal function over time is associated with major
bleeding in patients treated with direct oral anticoagulants for
atrial fibrillation. J Thromb Haemost. 16:833–841. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Skowrońska M, Furdyna A, Ciurzyński M,
Pacho S, Bienias P, Palczewski P, Kurnicka K, Jankowski K, Lipińska
A, Uchacz K, et al: D-dimer levels enhance the discriminatory
capacity of bleeding risk scores for predicting in-hospital
bleeding events in acute pulmonary embolism. Eur J Int Med.
69:8–13. 2019.PubMed/NCBI View Article : Google Scholar
|
